Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update

Go back to Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
(NASDAQ: NRIX) Delayed: 19.00 +0.35 (1.88%)
Previous Close $18.65    52 Week High
Open $18.49    52 Week Low
Day High $19.08    P/E N/A 
Day Low $18.39    EPS
Volume 509,270